about
The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptinLeptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studiesRole of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet AmyloidosisEffects of Experimental Sleep Restriction on Weight Gain, Caloric Intake, and Meal Timing in Healthy AdultsThe therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.Amylin activates distributed CNS nuclei to control energy balance.Central amylin acts as an adiposity signal to control body weight and energy expenditureAssociations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese.Acute hormonal response to glucose, lipids and arginine infusion in overweight cats.Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primatesEmerging pharmacotherapy for obesity.New pharmacological perspectives for the leptin receptor in the treatment of obesityNovel strategy for the use of leptin for obesity therapyDelayed response of amylin levels after an oral glucose challenge in children with Prader-Willi syndrome.Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice.The control of food intake: behavioral versus molecular perspectives.Fatty acids induce amylin expression and secretion by pancreatic beta-cells.The physiology underlying Roux-en-Y gastric bypass: a status report.Differential effect of amylin on endothelial-dependent vasodilation in mesenteric arteries from control and insulin resistant ratsEvidence for the role of hindbrain orexin-1 receptors in the control of meal size.Changes in Metabolic Hormones in Malaysian Young Adults following Helicobacter pylori Eradication.The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.Potential use of exenatide for the treatment of obesity.Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.Amylin acts in the central nervous system to increase sympathetic nerve activityCentral control of body weight and appetite.Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity.Thermodynamic and structural determinants of differential Pdx1 binding to elements from the insulin and IAPP promoters.The satiating hormone amylin enhances neurogenesis in the area postrema of adult rats.Proteasome regulates turnover of toxic human amylin in pancreatic cells.Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.Peripheral Pathways in the Food-Intake Control towards the Adipose-Intestinal Missing Link.Amylin/leptin synergy is absent in extreme obesity and not restored by calorie restriction-induced weight loss in rats.Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male ratsThe role of amylin in the control of energy homeostasis.Ghrelin: central nervous system sites of action in regulation of energy balance.Novel potential regulators of maternal adaptations during lactation: tuberoinfundibular peptide 39 and amylin.New drug targets for the treatment of obesity.Gastrointestinal hormones, energy balance and bariatric surgery.The central question of type 2 diabetes.
P2860
Q21261893-AD8618E9-2E70-4043-BB9B-3EB0810819F7Q24650977-3380044E-6C41-40CE-A863-0BE3C7D3A43FQ28088416-FED15884-EA4C-4AA6-8B7E-6CFDE516C04BQ28383665-1346AF4C-5845-41BF-AA7A-4E2844C52479Q33851630-38F88AC6-D4E5-4FAD-A41D-CEBBC5182735Q33962500-CD2BE8C3-4919-4510-9F8A-613B26EF5403Q33976258-8A31DCCC-D8F8-4177-B460-5924F5835153Q34026295-89E207F8-C930-4710-A3EC-910FBD2CFF61Q34125961-6BA86A34-A133-4FEC-BD9E-19236D23718FQ34150227-15BE7FFB-B213-4C65-870F-8632A0F045F9Q34207458-0C8C5CDC-97B5-41DE-9F80-A0E498D770EFQ34330557-D4CA98FF-E252-45D2-9C1A-18B3DC4D1BDCQ34454718-582CCECF-7CE6-4A05-9E17-BAF27AC88A93Q34635411-A213B288-6CE8-4C57-BE36-3A05EB0F1C36Q34718618-5E0B81CF-E3B2-4ABA-8624-B5572B91A90CQ34960476-C5B3BC3A-4539-49C8-95EB-D84C60369767Q35008762-00256DC0-C2AE-487A-8525-7361839EF872Q35043446-764F45AE-5E9F-4215-A6DE-71139CDE1821Q35217144-A19E8A98-4066-4A18-90EF-2F9AE342C63EQ35601574-BFB8F5B7-93AF-437E-9A4A-A12C41A8A378Q35751321-CF78AF03-7883-438A-B640-701FF271E67FQ36331824-082B3A99-0BFD-4F28-AD99-1F92211904ADQ36391466-2A15166E-7BB3-4C09-942E-E39DD3AB35D8Q36808109-8BEB4C67-E109-4610-90DE-99745158C5C7Q36946078-BD187CFB-401F-400F-B630-2FB7751052DCQ36979763-7DFAFEE6-36AD-4AF4-814B-BCE17AB8AA58Q37000812-8CAF1AA7-38F0-43FC-A563-57D7ECF21E3AQ37238174-F721A8E3-8951-415F-89A0-3034A7EACD7FQ37278570-0560F6DD-BD41-44A4-B260-A63403BCF55CQ37324490-95D44582-A488-485A-AC66-769A731932C1Q37368085-0858CF2A-7D35-4ECD-8BC5-553FBC15AAC9Q37408131-E2A1D2DF-4F46-4EE5-AA57-CD1A05608408Q37539627-8A21E750-781B-4F66-A22B-0EA1F675EDC6Q37709211-89E15BC9-2419-41FB-83F1-2101020699AEQ37722107-2391F303-18D1-417F-A3B2-B4573A704A75Q37783526-1716D45E-81C0-4C4C-ADE0-836D0FE9275EQ37854849-39ABBB52-0DC3-4C87-9860-DFDB20B9BD88Q37886661-A11FDC0A-3A0D-44DC-ACA9-FFB7EAA2BF10Q37930949-508E2728-C9A9-41AA-BF45-B3750775425EQ38162978-B29607D2-0C03-4495-BE20-8E9643288B79
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Amylinergic control of food intake.
@ast
Amylinergic control of food intake.
@en
type
label
Amylinergic control of food intake.
@ast
Amylinergic control of food intake.
@en
prefLabel
Amylinergic control of food intake.
@ast
Amylinergic control of food intake.
@en
P1476
Amylinergic control of food intake.
@en
P2093
Thomas A Lutz
P304
P356
10.1016/J.PHYSBEH.2006.04.001
P407
P577
2006-05-11T00:00:00Z